Fluvac Innovator ( Flu ) Equine Influenza (KY 97) Vaccine (KV) Protects healthy horses against Kentucky 97, the most current A1 and A2 influenza strain in an equine vaccine. See Allivet's Horse Vaccine Chart to find out which vaccine is right for your horse.
This item is already on your autoship schedule! Are you sure you want to add it again?
Fluvac Innovator ( Flu ) Equine Influenza (KY 97) Vaccine (KV) Protects healthy horses against Kentucky 97, the most current A1 and A2 influenza strain in an equine vaccine.
Who is Fluvac Innovator for?
Why use Fluvac Innovator?
-Protect healthy horses from equine influenza due to type A2 viruses.
How Fluvac Innovator work?
Equine Influenza Vaccine Killed Virus aids in the prevention of equine influenza due to type A2 viruses.
Equine Influenza Vaccine Killed Virus
How is Fluvac Innovator sold?
1 ds Syringe & 10 ds Vial
What special precautions are there?
Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
What to do if overdose?
Contact your nearest emergency animal hospital.
How can I store Fluvac Innovator?
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING.
Equine influenza is one of the most common horse respiratory diseases. The contagious disease can cause fever, coughing and nasal discharge. Equine Influenza can spread rapidly among groups of horses. Much like other respiratory diseases, EIV can be a source of economic loss because of missed training days and additional veterinary costs.
DOSAGE AND ADMINISTRATION: Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually.
Equine Influenza Vaccine Killed Virus.
Thimerosal, neomycin and polymyxin B added as preservatives.
Equine influenzacaused by the orthomyxovirus equine influenza A type 2 (A/equine 2), is one of the most common infectious diseases of the respiratory tract of horses.Equine influenza virus does not constantly circulate, even in large groups of horses, but is sporadically introduced by an infected horse. This epidemiologic finding and the rapid elimination of the virus by the equine immune response suggest that infection can be avoided by preventing entry of the virus into an equine population (i.e. by the quarantine of newly arriving horses for at least 14 days), and by appropriate vaccination before exposure. All horses should be vaccinated against equine influenza unless they live in a closed and isolated facility.
To date, the most important factors associated with increased risk of infection have been identified as:
Age: Horses 1 to 5 years old are more susceptible. Older horses are generally less susceptible to infection, but immunity can be overwhelmed in horses frequently exposed at shows or similar athletic events
Serum concentrations of influenza virus-specific antibody: The importance of local mucosal protection is difficult to quantitate by methods currently available.
INNOVATOR is for vaccination of healthy horses as an aid in the prevention of equine influenza due to type A2viruses, contains the MetaStim adjuvant, which virtually eliminates post-vaccination reactions and extends disease protectio
FLUVAC INNOVATOR vaccines aid in the prevention of equine influenza due to type A2viruses; equine rhinopneumonitis due to equine herpes virus (EHV) types 1 and 4; equine encephalomyelitis due to Eastern, Western and Venezuelan viruses; and tetanus
FLUVAC INNOVATOR is veterinarian’s first choice for flue-rhino protect
FLUVAC INNOVATOR is the only vaccine with EVI that has demonstrated protection against heterologous challenge.
FLUVAC INNOVATOR is the only EIV vaccine shown to help protect against clinical signs for seven months against a heterologous, dual-strain challenge.
In addition to EIV, FLUVAC INNOVATOR vaccines also contain both EHV-1 and EHV-4 to help protect against rhinopneumonitis.
Only INNOVATOR vaccines are adjuvanted with MetaStim for improved immune response.
Directions: Inject 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose in unvaccinated or naïve horses. A 1 mL annual revaccination in previously vaccinated horses is recommended.Always read and follow label indications